TransCanada (TRP) Misses Q2 EPS by 4c, Sales Also Light

TransCanada (NYSE: TRP) reported Q2 EPS of $0.43, $0.04 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $1.91 billion versus the consensus estimate of $2.24 billion.

(All figures in Canadian dollars.)

For earnings history and earnings-related data on TransCanada (TRP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
• Aeroflex Holdings (ARX) Tops Q2 EPS by 15c
• Zenas BioPharma, Inc. (ZBIO) Reports Q2 Loss of $1.77